BCKDK and cancer: To further verify that the effects of EAAm on cancer cells viability, glycolysis inhibition, ER stress induction, and mTORC1 inhibition were due to the activation of BCAA catabolism, we treated M14 and Hela cells with the BCKDK inhibitor BT2 [58].